Foley & Lardner LLP is pleased to announce the Center for Cancer and Blood Disorders in Fort Worth, Texas as the recipient of its tenth annual Cancer Center Innovator Award. The 2017 award was accepted by Barry Russo, CEO of the Center for Cancer and Blood Disorders.
“We are proud to honor Mr. Russo and the entire Center for Cancer and Blood Disorders organization for its leadership in supporting alternative payment arrangements in oncology care,” said Michael Blau, a Foley partner and health care attorney. “They not only lead by example, but also encourage other cancer care providers to explore similar high-quality care initiatives by sharing their learnings from the numerous pilot programs in which they have participated.”
A few initiatives to highlight include:
“We are honored to receive Foley’s 2017 Cancer Center Innovator Award,” said Russo. “With the rising cost of oncology care, our team sees growing importance to seek out opportunities to provide outstanding quality of care while lowering the cost of cancer care through these pilot programs and initiatives. It is great to see others in the industry learning from our experience and getting on the bandwagon.”
Foley’s Cancer Center Innovator Award was established in 2007 to recognize top innovators in the business of community cancer care delivery. This year’s selection was made by the Cancer Center Business Summit Advisory Board and co-hosts. The co-hosts include the Association of Community Cancer Centers, NantHealth, Cancer Center Business Development Group, and Foley’s Michael Blau.
The 2017 Cancer Center Business Summit brings together industry leaders to explore best practices to adapt to change, and position for future success, in the business of community oncology care. For more information about this year’s event, please visit http://cancerbusinesssummit.com.